Arie Belldegrun, Director at Arno Therapeutics, Inc (ARNI), bought 4,324,694 shares at $0.35 ($1.5M) on 2016-01-12, disclosed to the SEC on 2016-01-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.35 | 714,285 | $250K | 16.5% |
| 2 | $0.35 | 714,285 | $250K | 16.5% |
| 3 | $0.35 | 1,448,062 | $507K | 33.5% |
| 4 | $0.35 | 1,448,062 | $507K | 33.5% |
| Total | $0.35 avg | 4,324,694 | $1.5M | 100% |
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |